Cadisegliatin by VTv Therapeutics for Type 1 Diabetes (Juvenile Diabetes): Likelihood of Approval
Cadisegliatin is under clinical development by vTv Therapeutics and currently in Phase III for Type 1 Diabetes (Juvenile Diabetes).
Cadisegliatin is under clinical development by vTv Therapeutics and currently in Phase III for Type 1 Diabetes (Juvenile Diabetes).